Spread without known selective pressure of a vancomycin-resistant clone of Enterococcus faecium among broilers

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 5, 2009, Pages 868-872

  Nilsson, Oskar ^a   Greko, C ^a   Top, J ^b   Franklin, A ^a   Bengtsson, B ^a  

^a NATIONAL VETERINARY INSTITUTE   (Sweden)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Epidemiology; MLST; VanA

Indexed keywords

AMPICILLIN; ERYTHROMYCIN; NARASIN; UNCLASSIFIED DRUG; VANCOMYCIN; VANCOMYCIN A;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHICKEN; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; TRANSPOSON; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CARBON-OXYGEN LIGASES; CECUM; CHICKENS; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA TRANSPOSABLE ELEMENTS; ENTEROCOCCUS FAECIUM; GENOTYPE; GRAM-POSITIVE BACTERIAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; POULTRY DISEASES; SELECTION (GENETICS); SEQUENCE ANALYSIS, DNA; SWEDEN; VANCOMYCIN RESISTANCE;

EID: 64649091464     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp045     Document Type: Article

References (20)

1. Bonten MJ, Willems R, Weinstein RA. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1: 314-25.
2. Leclercq R, Derlot E, Duval J et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-61.
3. Bager F, Madsen M, Christensen J et al. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev Vet Med 1997; 31: 95-112.
4. Aarestrup FM, Seyfarth AM, Emborg HD et al. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother 2001; 45: 2054-9.
5. Wierup M, Lowenhielm C, Wold-Troell M et al. Animal consumption of antibiotics and chemotherapeutic drugs in Sweden during 1980, 1982 and 1984. Vet Res Commun 1987; 11: 397-405.
6. Quednau M, Ahrne S, Petersson AC et al. Antibiotic-resistant strains of Enterococcus isolated from Swedish and Danish retailed chicken and pork. J Appl Microbiol 1998; 84: 1163-70.
7. Kuhn I, Iversen A, Finn M et al. Occurrence and relatedness of vancomycin-resistant enterococci in animals, humans, and the environment in different European regions. Appl Environ Microbiol 2005; 71 5383-90.
8. SVARM 2007. In: Bengtsson B, Greko C, Grönlund-Andersson U, eds. Swedish Veterinary Antimicrobial Resistance Monitoring. ISSN 1650-6332. The National Veterinary Institute (SVA), Uppsala, Sweden, 2008.
9. Devriese LA, Pot B, Collins MD. Phenotypic identification of the genus Enterococcus and differentiation of phylogenetically distinct enterococcal species and species groups. J Appl Bacteriol 1993; 75: 399-408.
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disc and Dilution Susceptibility Tests for Bacteria Isolated from Animals - Third Edition: Approved Standard M31-A3. CLSI, Wayne, PA, USA, 2008.
11. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33: 24-7.
12. Homan WL, Tribe D, Poznanski S et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol 2002; 40: 1963-71.
13. Woodford N, Adebiyi AM, Palepou MF et al. Diversity of VanA glycopeptide resistance elements in enterococci from humans and non-human sources. Antimicrob Agents Chemother 1998; 42: 502-8.
14. Aarestrup FM. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb Drug Resist 1995; 1: 255-7.
15. Klare I, Badstubner D, Konstabel C et al. Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist 1999; 5: 45-52.
16. Borgen K, Simonsen GS, Sundsfjord A et al. Continuing high prevalence of VanA-type vancomycin-resistant enterococci on Norwegian poultry farms three years after avoparcin was banned. J Appl Microbiol 2000; 89: 478-85.
17. Garcia-Migura L, Liebana E, Jensen LB et al. A longitudinal study to assess the persistence of vancomycin-resistant Enterococcus faecium (VREF) on an intensive broiler farm in the United Kingdom. FEMS Microbiol Lett 2007; 275: 319-25.
18. SWEDRES 2007. In: Struwe J, Olson-Liljequist B, eds. Swedish Strategic Programme for the Rational Use of Antimicrobial Agents & Swedish Institute for Disease Control. ISSN 1400-3473. The Swedish Institute for Infectious Disease Control, Solna, Sweden, 2008.
19. Iversen A, Kuhn I, Franklin A et al. High prevalence of vancomycin-resistant enterococci in Swedish sewage. Appl Environ Microbiol 2002; 68: 2838-42.
20. Sahlström L. Recycled Biowaste as a Source of Infection. Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences, Uppsala, 2006. http://diss-epsilon.slu.se/ archive/00001170/01/Avhandling_nr_070.2006_Tryckfil.pdf (08 January 2009, date last accessed).